Advertisement

Topics

Biomarkers Companies in BioPortfolio's Corporate DatabaseTwitter RSS

17:38 EDT 21st October 2017 | BioPortfolio

Biomarkers company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Biomarkers companies that have been added to our BioPortfolio's life-science corporate directory.

Search For More Biomarkers Companies

If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Biomarkers Companies.

More Information about Biomarkers on BioPortfolio

We have published hundreds of Biomarkers news stories on BioPortfolio along with dozens of Biomarkers Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Biomarkers for you to read.

Showing "biomarkers biomarker" Companies 1 to 25 of 228

Monday 2nd October 2017

Maven Biotechnologies

Maven Biotechnologies (www.mavenbiotech.com) is a privately-held biotechnology company located in Pasadena, CA. The company has developed LFIRE(TM) [pronounced: el - fire] - a flexible, cost-effective, high density imaging technology for the multiplexed, quantitative, label-free, real-time characterization of biomarker binding reactions. The platform addresses applications in biomedical research, ...

Tuesday 26th September 2017

ABL, Inc. and Aushon BioSystems

Aushon BioSystems, Inc. is leading the way in protein biomarker discovery, development and analysis. Through the unique combination of proprietary microarray printing, extensive biomarker content and ease-of-use, the Cira™ immunoassay platform is serving leading pharmaceutical companies, contract research organizations and clinical reference laborator...

Pliant Therapeutics, Inc.

Pliant Therapeutics is an early-stage biotechnology company harnessing the therapeutic capabilities of integrin biology and TGF-β signaling to develop breakthrough treatments for fibrotic diseases. By leveraging its powerful product engine, Pliant’s mission is to prevent or even reverse fibrosis, restoring organ function. The company also aims to build a ...

Thursday 21st September 2017

Powering Precision Health

The official sponsors partnering with the summit to bring precision health technologies to the forefront of medicine include premier sponsor Quanterix, the leading company digitizing biomarker analysis with the goal of advancing the science of precision health, and leading precision health companies: Pfizer, Origene (including BioCheck, Casi,...

Tuesday 25th July 2017

Venebio Group

Venebio is a research consultancy that provides cost-effective, custom solutions for complex life sciences problems. By integrating the expertise of a global network of scientists in a broad range of biomedical fields, Venebio delivers comprehensive project management and problem solving in genetic and molecular epidemiology, pharmacoepidemiology and pharm...

Monday 17th July 2017

Minomic International Ltd

Minomic International Ltd is an Australian immuno-oncology company specialising in therapeutics and diagnostics for prostate cancer and other cancers. Minomic has developed the in vitro diagnostic test called MiCheck® for the early detection of prostate cancer. Minomic is preparing to globally launch its first product, a novel prostate cancer blood test...

Thursday 29th June 2017

Biodesy, Inc.

Biodesy is developing the first products and systems to rapidly and inexpensively measure both protein structure and function in real time, with applications including drug discovery, structural biology, and clinical biomarkers. Biodesy has developed a unique and highly sensitive technology for detecting conformational change in proteins and other biologic...

Wednesday 14th June 2017

CellMax Life

CellMax Life, Inc. is a precision cancer blood-testing company providing comprehensive, personalized multi-biomarker technology platforms for genetic cancer risk assessment, early detection and personalized treatment of cancer. CellMax Life’s products include CellMax-DNA Genetic Cancer Risk Test, CellMax-LBx Liquid Biopsy, and CellMax-CRC Colorectal C...

Tuesday 6th June 2017

Abreos Biosciences

Abreos Biosciences is focused on ligand binding assays for biologic and biosimilar drug development, activity validation, authentication, and precision dosing, as well as massively multiplexed biomarker assays. Abreos has already developed reagents for the detection of several drugs currently available on the market such as rituximab, obinutuzumab, trastuz...

Monday 15th May 2017

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology investigates biomarkers at the structural level as opposed to overall concentration, giving better insights as to its cellular origin. Its pipeline of high performance, non-invasive ca...

Tuesday 2nd May 2017

Lantern Pharma Inc.

Lantern Pharma is a biotech company aiming to re-invent the cancer drug development process by tailoring promising drug programs to the right cancer patients through biomarker discovery. Lantern leverages advanced genomics and machine learning based artificial intelligence (AI) to identify and significantly reduce the cost and overall risk profile of new t...

Medicortex Finland Oy

Medicortex Finland Oy (http://www.medicortex.fi) is a biotechnology company dedicated to improving the diagnostics and treatment of Traumatic Brain Injury (TBI). Is currently developing biomarker diagnostics that evaluate the extent and severity of TBI. Once the company completes this test its next goal will be to develop an innovative drug to halt the pro...

Friday 28th April 2017

Cambridge Epigenetix

Cambridge Epigenetix’s mission is to improve health through the routine measurement of the epigenome. Cambridge Epigenetix utilizes innovative technologies, often based on fundamental chemistry, to detect the epigenetic biomarkers that will be most useful in clinical settings. Spun-out of the University of Cambridge in 2012, the Company was founded ...

Thursday 27th April 2017

Mellitus, LLC

Mellitus is dedicated to advancing diabetes detection and monitoring through products based on GCD59, a biomarker of glycemic load that is unique because of its direct relationship to the complications of diabetes. Our premier application is a patient-friendly test for gestational diabetes, enabling more timely intervention to improve the health of both mo...

Wednesday 26th April 2017

Medicortex

Medicortex Finland Oy (http://www.medicortex.fi) is a biotechnology company dedicated to improving the diagnostics and treatment of Traumatic Brain Injury (TBI). Its current focus is to develop biomarker diagnostics that evaluate the extent and severity of TBI. Once the company completes this test its next goal will be to develop an innovative drug to halt...

Thursday 23rd March 2017

Ultivue Inc.

Founded by world-leading experts in biomolecular analysis, Ultivue is a venture-backed company developing reagent-driven solutions for high-definition biological imaging in situ, combining unlimited multiplexing at high speed with high spatial resolution. Ultivue’s proprietary reagents, instruments, and bioinformatics tools will enable researchers and...

Friday 17th March 2017

Prevencio, Inc.

Prevencio, a development stage company, is pioneering multiplex proteomic cardiac biomarker diagnostic tests for ruling out obstructive coronary artery disease in chest pain patients in the emergency room. The Company's proprietary HART™ Test will be a first-in-class product. The worldwide market potential for the HART™ Test is estimated to be $2 ...

Thursday 23rd February 2017

Fusion Pharmaceuticals

Fusion Pharmaceuticals is a new pharmaceutical company located in Hamilton, Ontario, Canada focused on becoming the leader in the targeted alpha therapy field. Fusion will exploit its unique expertise in linking medical isotopes to targeting molecules to create highly effective therapeutics. In addition to its lead program, FPX-01, Fusion is building a pip...

Tuesday 21st February 2017

DiaCarta, Inc.

DiaCarta is an innovative precision molecular diagnostic company headquartered in Richmond, California. The company has an ISO 13485-certified facility, which is used to develop, manufacture and market a range of cancer research and IVD products. DiaCarta specializes in genomic testing for biomarkers and offers clinical sample testing services in a CLIA-ce...

Thursday 9th February 2017

NeuroPointDX

NeuroPointDX is the diagnostics division of Stemina Biomarker Discovery. Stemina is a biotechnology company based in Madison, WI and Cambridge, MA that has developed a robust and reproducible proprietary platform for identifying changes in metabolism (“biomarkers”) utilizing highly sensitive analytical equipment and its proprietary platform technology. ...

Saturday 4th February 2017

Quanterix Corporation Quanterix

Quanterix is a company that’s digitizing biomarker analysis to advance the science of precision health. The company’s digital health solution, Simoa, is changing the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. In doing so, Quanterix enables much earlier disease ...

Thursday 3rd March 2016

The FlowMetric Family of Companies

The FlowMetric Family of Companies consist of FlowMetric, Inc. and two additional affiliate companies, FlowMetric Europe, S.p.A. and FlowMetric Diagnostics, Inc. FlowMetric, Inc. and FlowMetric Europe, S.p.A., founded in 2010 and 2013 respectively, are niche contract research organizations (CROs), focused on providing polychromatic flow cytometry and cell ...

Wednesday 2nd March 2016

Xcell Biosciences, Inc.

Xcell Biosciences, Inc., is developing revolutionary products and workflows for life science and translational research that reproduce physiologically relevant conditions to enable more meaningful, biologically relevant experiments. The company’s tools empower scientists to obtain accurate and actionable results in important fields such as cancer rese...

Tuesday 23rd February 2016

Ignyta Inc.

At Ignyta, we fight cancer – a formidable opponent that manifests as thousands of different molecularly defined diseases and takes away millions of lives globally, every year. In this fight, our big hairy audacious goal (BHAG) is not just to shrink tumors but to eradicate residual disease – the source of cancer relapse and recurrence – in pr...

Thursday 18th February 2016

Pliant Therapeutics

Pliant Therapeutics is an early-stage biotechnology company harnessing the therapeutic capabilities of integrin biology and TGF-β signaling to develop breakthrough treatments for fibrotic diseases. By leveraging its powerful product engine, Pliant’s mission is to prevent or even reverse fibrosis, restoring organ function. The company also aims to build a ...


More From BioPortfolio on "Biomarkers Companies in BioPortfolio's Corporate Database"

Quick Search
Advertisement
 

Corporate Database Quicklinks